Keywords: Takeda, Actos, Patents, USA, Mylan, Watsson, Ranbaxy, Teva, Type 2 diabetes

Takeda settles Actos patent law suits with Mylan, Watson and Ranbaxy, as well as Teva and others

Article | 22 December 2010

Print This

Japan’s largest drugmaker, Takeda Pharmaceutical (TYO: 4502), and its US subsidiary have completed settlements with all defendants in patent ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in